Dr. Denise Faustman

Patient Leader

Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. Her current research focuses on discovering and developing new treatments for type 1 diabetes and other autoimmune diseases. She is currently leading a human clinical trial program that is testing the efficacy of the BCG vaccine--better known for its use in tuberculosis prevention--for a new use: the reversal of long-term type 1 diabetes. The BCG vaccine is a safe, relatively inexpensive, generic drug that may be a low-cost option for improving type 1 diabetes for the many people who have been living with this disease for years. In a Phase I clinical trial, the drug temporarily restored insulin production in patients who had type 1 diabetes for an average of 15 years. A Phase II human clinical trial is currently being planned.

Nominations

Best Kept Secret Geek Health Activist Health Activist Hero

Dr. Faustman is doing amazing research into a cure for Type 1 diabetes. While the cure may be too late for my mother, my sister-in-law and I to take advantage of, when (not if) it comes, it will change the lives of so many children and young people around the world.  — Nancy

She will find a cure to Type 1 diabetes :)

Dr Faustman is a pioneer in reversing T1 Diabetes in humans. While all other pharmaceutical companies are content with treating the disease, Dr Faustman wont stop until it is cured....  — David

Her relentless search for a cure for T1 Diabetes isn't getting the attention it deserves and needs to progress to Phase 2 in clinical research- with the hope of reversing T1 diabetes permanently with a generic (meaning very low cost) and already approved vaccine (for other indications)...  — Michelle

She discovered about 11 years ago or more that the vaccine against TB also cures diabetes type 1 in mice as well as possibly other autoinmune disorders. She has been trying to raise funds to complete her studies, but even organizations who supossedly look for a cure do not support her because no one will make money out of curing diabetes type 1 with an old and very cheap vaccination. Yet she continues resarching and tyring to raise funds to advance to phase III of the research. She is the best realistic hope for diabees type 1 cure.  — Rita

Dr. Denise Faustman

You Might Also Like

HEALTH COMMUNICATION (COM SALUD BLOG)

Best in Show: Blog Nominee

Best in Show: Blog Nominee

Dr. Ravi

Health Activist Hero Nominee

Best in Show: Facebook Nominee

KidChefEliana

Health Activist Hero Nominee

Meri

Best in Show: Blog Nominee

Best in Show: Twitter Nominee

Atrium Wellness Massage

Best Kept Secret Nominee

Jenni Grover

Best in Show: Community⁄Forum Nominee

Best in Show: Facebook Nominee